pembrolizumab
merck
['hncsm', 'keynote-412', 'improve ', 'pembro']
at #esmo22: results from keynote-412 showed that adding pembrolizumab to chemoradiation did not significantly improve efs or os in hnscc. #hncsm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.